CHEST Journal Podcasts

Should BAL Be Routinely Performed in the Diagnostic Evaluation of IPF?

Athol U. Wells, MD, and Joshua J Mooney, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to debate whether bronchoalveolar lavage should be a standard diagnostic tool for IPF. The discussion centers on the lack of evidence-based agreement on the value of performing BAL.

IVIg to Treat Severe Refractory HIT

Anand Padmanabhan, MD, PhD, and editorialist Theodore Warkentin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Padamanabhan et al, which describes outcomes in three patients with heparin-induced thrombocytopenia (HIT) who responded well to IVIg therapy.

Physician Assessment of Probability in Predicting Malignancy and Adherence with Guidelines

Nichole T. Tanner, MD, MSCR, FCCP, and editorialist Jonathan M. Iaccarino, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the accuracy of physician assessment in predicting malignancy in pulmonary nodules. Although adept at recognizing the pretest probability of malignancy, physicians would provide better patient care if they had followed guideline-recommended next steps in evaluation.

Wireless Pulmonary Artery Hemodynamic Monitoring for Pulmonary Hypertension?

Mark J. Zucker, MD, JD, FCCP, and Anne R. Hemnes, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to review the pros and cons of their Point/Counterpoint debate, “Should Wireless Pulmonary Artery Hemodynamic Monitoring Be Used to Monitor Patients With Pulmonary Hypertension?”

Hydrocortisone, Vitamin C, and Thiamine for Treatment of Sepsis

Paul E. Marik, MD, FCCP, and Editorialist Heleen M. Oudemans-van Straaten, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss Dr. Marik and colleagues' retrospective study of the effectiveness in treating patients with severe sepsis and specific shock with the early use of intravenous vitamin C, together with corticosteroids and thiamine.

Cross-Disciplinary Analysis of Lymph Node Classification

Ahmed H. El-Sherief, MD, and editorialist Galit Aviram, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss the study by Dr. El-Sherief and others on the inconsistencies in lymph node classification and the need for a lymph node map that simultaneously communicates a standard set of lymph node station definitions in three languages—using the language of anatomic landmarks for surgeons, bronchoscopic landmarks for pulmonologists, and visual CT landmarks for radiologists.

Should Acute Fluid Resuscitation Be Guided Primarily by Inferior Vena Cava Ultrasound for Patients in Shock?

Gregory A. Schmidt, MD, FCCP, and Pierre Kory, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss their Point/Counterpoint debate on the value of inferior vena cava ultrasound to determine the use of acute fluid resuscitation for patients in shock.

Estimating Ten-Year Trends in Septic Shock Incidence

Chanu Rhee, MD, MPH, and Robert C. Hazy, MD, FCCP, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to review and analyze the results of Dr. Rhee et al's research estimating incidences and mortality of septic shock over a ten-year period. Their results showed that the incidence has risen but mortality rates have fallen.

Risks for Patients Under Consideration for IVC Filters

Brian Funaki, MD, and Mark L. Lessne, MD, joint CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss this month's Point/Counterpoint debate: Do the Benefits Outweigh the Risks for Most Patients Under Consideration for Inferior Vena Cava Filters?

Autofluorescence Bronchochoscopy Detected Low Prevalence of High-Grade Lesions in LC Screening

Alain Tremblay, MD, and editorialist David E. Ost, MD, FCCP, joined CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the research by multi-center Canadian study by Tremblay et al that evaluated how well autofluorescence bronchochoscopy (AFB) detected high-grade lesions in patients at risk for lung cancer. Their study determined that too few CT occult cancers were detected to justify its addition into a lung cancer screening program.